Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal Permeability Is Associated with Mortality and Readmission in Children Hospitalized with Severe Acute Malnutrition.

The Journal of nutrition·2026
Same author

Corrigendum to 'The Environmental Enteric Dysfunction Biopsy Initiative (EEDBI) Consortium: mucosal investigations of EED' [The American Journal of Clinical Nutrition. 2024; 120S1: S4-S14].

The American journal of clinical nutrition·2026
Same author

Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers: a prospective multi-centre study.

Journal of travel medicine·2026
Same author

Erratum: Intestinal microbiome changes in response to amino acid and micronutrient supplementation: secondary analysis of the AMAZE trial - CORRIGENDUM.

Gut microbiome (Cambridge, England)·2026
Same author

Small intestinal microbiota in Zambian children with stunting and severe acute malnutrition.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Same author

A meta-analysis of gut microbiome research in malnourished African populations: a natural language processing approach.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

What's new in TB?

Anna Ralph1, Paul Kelly, Vicki Krause

  • 1National Centre for Epidemiology and Population Health, Australian National University, Australia. anna.ralph@anu.edu.au

Australian Family Physician
|November 7, 2009
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) is rising in Australia, particularly among Indigenous populations and migrants. New diagnostic and management strategies are crucial for combating drug-resistant TB and HIV-TB co-infection.

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Related Experiment Videos

Last Updated: Jun 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Area of Science:

  • Public Health
  • Infectious Diseases
  • General Practice

Background:

  • Australia has low overall tuberculosis (TB) rates but faces increasing incidence among Indigenous populations and migrants.
  • TB remains a significant global cause of morbidity and mortality, with rising rates linked to immigration patterns and global TB trends.
  • Specific challenges include managing TB in Indigenous communities and adapting to changing demographics.

Purpose of the Study:

  • To review recent developments in TB diagnosis and management relevant to Australian general practice.
  • To update general practitioners on advances in TB care.
  • To clarify the role of general practitioners in co-managing TB patients.

Main Methods:

  • Literature review of recent advancements in TB diagnosis and management.
  • Analysis of trends in TB incidence in Australia.
  • Focus on challenges posed by multidrug-resistant TB (MDR-TB) and HIV-TB co-infection.

Main Results:

  • Experience with imported multidrug-resistant TB (MDR-TB) is increasing in Australia.
  • The prevalence of extensively drug-resistant TB is also expanding.
  • Progress in TB understanding, diagnosis, and management is driven by MDR-TB and HIV-TB co-infection challenges.

Conclusions:

  • General practitioners play a vital role in co-managing TB patients.
  • Adapting to imported MDR-TB and HIV-TB co-infection requires updated knowledge and strategies.
  • While standard guidelines for drug-susceptible TB persist, advancements are essential for comprehensive TB control.